Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. [electronic resource]
Producer: 20190325Description: 78-88 p. digitalISSN:- 1523-1747
- Adaptor Proteins, Signal Transducing -- metabolism
- Adult
- Animals
- Biopsy
- Bleomycin -- toxicity
- Cell Cycle Proteins
- Cell Nucleus -- metabolism
- Cells, Cultured
- Dimethyl Fumarate -- pharmacology
- Disease Models, Animal
- Female
- Fibroblasts
- Fibrosis
- Humans
- Intracellular Signaling Peptides and Proteins -- metabolism
- Male
- Mice
- Mice, Inbred C57BL
- Middle Aged
- Phosphatidylinositol 3-Kinase -- metabolism
- Phosphoproteins -- metabolism
- Proteolysis -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Scleroderma, Systemic -- drug therapy
- Signal Transduction -- drug effects
- Skin -- drug effects
- Trans-Activators
- Transcription Factors
- Transcriptional Coactivator with PDZ-Binding Motif Proteins
- Transforming Growth Factor beta -- metabolism
- Treatment Outcome
- YAP-Signaling Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.